نتایج جستجو برای: msa model

تعداد نتایج: 2106435  

2008
Zhonghe Wu

The purpose of this research was to contribute to a better understanding of how to enhance pre-service teachers’ knowledge of mathematics teaching through Model, Strategy, and Application (MSA). 153 pre-service teachers from six math methods courses (K-8) at two universities participated in this study. Both qualitative and quantitative methods were used to measure teacher learning and understan...

2005
Won Tae Yoon Eun Joo Chung Sang Hyeon Lee Byung Joon Kim Won Yong Lee

BACKGROUND AND PURPOSE Blepharospasm (BSP) and apraxia of eyelid opening (AEO) have been reported as dystonia related with parkinsonism. However, systematic analysis of clinical characteristics of BSP and AEO in parkinsonism has been seldom reported. To investigate the clinical characteristics of BSP and AEO in parkinsonism and to find out the clinical significance to differentiate parkinsonism...

2012
Sang-Wook Lee Seong-Beom Koh

Multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are an adult-onset progressive neurodegenerative disorder that are known to display diverse clinical features and disease progression. We aim to characterize the clinical features and disease progression in patients with MSA and PSP by using a number of relevant disability milestones in Koreans. Forty-one patients with MSA a...

2017
Carlos E. Mendoza-Santiesteban Iñigo Gabilondo Jose Alberto Palma Lucy Norcliffe-Kaufmann Horacio Kaufmann

BACKGROUND Multiple system atrophy (MSA) is a rare, adult-onset, rapidly progressive fatal synucleinopathy that primarily affects oligodendroglial cells in the brain. Patients with MSA only rarely have visual complaints, but recent studies of the retina using optical coherence tomography (OCT) showed atrophy of the peripapillary retinal nerve fiber layer (RNFL) and to a lesser extent the macula...

Journal: :Rinsho shinkeigaku = Clinical neurology 2014
Shoji Tsuji

To elucidate molecular bases of multiple system atrophy (MSA), we first focused on recently identified MSA multiplex families. Though linkage analyses followed by whole genome resequencing, we have identified a causative gene, COQ2, for MSA. We then conducted comprehensive nucleotide sequence analysis of COQ2 of sporadic MSA cases and controls, and found that functionally deleterious COQ2 varia...

Journal: :Movement disorders : official journal of the Movement Disorder Society 2009
Tatsuya Yamamoto Ryuji Sakakibara Tomoyuki Uchiyama Zhi Liu Takashi Ito Yusuke Awa Tomonori Yamanishi Takamichi Hattori

Multiple system atrophy (MSA) is a neurodegenerative disease characterized clinically by any combination of autonomic, cerebellar, and extrapyramidal symptoms. Autonomic symptoms are usually severe, and urinary symptoms are one of the cardinal features of MSA. Bowel dysfunction and sexual dysfunction are also common in MSA. Quality of life (QOL) in patients with MSA is severely impaired by the ...

Journal: :Movement disorders : official journal of the Movement Disorder Society 2008
Martin Köllensperger Felix Geser Klaus Seppi Michaela Stampfer-Kountchev Martin Sawires Christoph Scherfler Sylvia Boesch Joerg Mueller Vasiliki Koukouni Niall Quinn Maria Teresa Pellecchia Paolo Barone Nicole Schimke Richard Dodel Wolfgang Oertel Erik Dupont Karen Østergaard Christine Daniels Günther Deuschl Tanya Gurevich Nir Giladi Miguel Coelho Cristina Sampaio Christer Nilsson Håkan Widner Francesca Del Sorbo Alberto Albanese Adriana Cardozo Eduardo Tolosa Michael Abele Thomas Klockgether Christoph Kamm Thomas Gasser Ruth Djaldetti Carlo Colosimo Giuseppe Meco Anette Schrag Werner Poewe Gregor K Wenning

The clinical diagnosis of multiple system atrophy (MSA) is fraught with difficulty and there are no pathognomonic features to discriminate the parkinsonian variant (MSA-P) from Parkinson's disease (PD). Besides the poor response to levodopa, and the additional presence of pyramidal or cerebellar signs (ataxia) or autonomic failure as major diagnostic criteria, certain other clinical features kn...

2014
Anthony S Don Jen-Hsiang T Hsiao Jonathan M Bleasel Timothy A Couttas Glenda M Halliday Woojin Scott Kim

Multiple system atrophy (MSA) is a rapidly-progressive neurodegenerative disease characterized by parkinsonism, cerebellar ataxia and autonomic failure. A pathological hallmark of MSA is the presence of α-synuclein deposits in oligodendrocytes, the myelin-producing support cells of the brain. Brain pathology and in vitro studies indicate that myelin instability may be an early event in the path...

2017
Ha Na Kim Dong Yeol Kim Se Hee Oh Hyung Sook Kim Kyung Suk Kim Phil Hyu Lee

Multiple system atrophy (MSA) is a sporadic neurodegenerative disease of the central and autonomic nervous system. Because no drug treatment consistently benefits MSA patients, neuroprotective strategy using mesenchymal stem cells (MSCs) has a lot of concern for the management of MSA. In this study, we investigated the safety and efficacy of intra-arterial administration of MSCs via internal ca...

2017
Ronald J. Mandel David J. Marmion Deniz Kirik Yaping Chu Clifford Heindel Thomas McCown Steven J. Gray Jeffrey H. Kordower

Multiple system atrophy (MSA) is a horrible and unrelenting neurodegenerative disorder with an uncertain etiology and pathophysiology. MSA is a unique proteinopathy in which alpha-synuclein (α-syn) accumulates preferentially in oligodendroglia rather than neurons. Glial cytoplasmic inclusions (GCIs) of α-syn are thought to elicit changes in oligodendrocyte function, such as reduced neurotrophic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید